A variant in the CD209 promoter is associated with severity of dengue disease

Anavaj Sakuntabhai, Chairat Turbpaiboon, Isabelle Casadémont, +18

Nature Genetics

Dengue DiseaseDisease SusceptibilityAutoimmune DiseaseMedicineGenetics +9

Rapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans

Jens Wrammert, Nattawat Onlamoon, Rama Akondy, +12

Journal of Virology

Dengue Virus Infection Induces Expansion of a CD14+CD16+ Monocyte Population that Stimulates Plasmablast Differentiation

Marcin Kwissa, Helder I. Nakaya, Nattawat Onlamoon, +8

Cell Host & Microbe

PathogenesisViral PathogenesisImmunologyVirologyVirus-host Interaction +4

Diagnostic Accuracy of NS1 ELISA and Lateral Flow Rapid Tests for Dengue Sensitivity, Specificity and Relationship to Viraemia and Antibody Responses

Vu Ty Hang, Nguyet Minh Nguyen, Dinh The Trung, +8

PLoS neglected tropical diseases

Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests

Elizabeth A. Hunsperger, Sutee Yoksan, Philippe Buchy, +16

Emerging infectious diseases

Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

Thomas P. Monath, Karen McCarthy, Philip Bedford, +8

Vaccine

VaccinationVaccine DevelopmentVaccine ResearchImmunologyVirology +5

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

Thomas P. Monath, Farshad Guirakhoo, Richard Nichols, +9

The Journal of Infectious Diseases

An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection

Claire M. Midgley, Martha Bajwa-Joseph, Sirijitt Vasanawathana, +13

Journal of Virology

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

Farshad Guirakhoo, Scott Kitchener, Dennis Morrison, +11

Human Vaccines

Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody

Elizabeth A. Hunsperger, Sutee Yoksan, Philippe Buchy, +15

PLoS neglected tropical diseases